Clinical Trials Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Dec 14, 2017; 23(46): 8217-8226
Published online Dec 14, 2017. doi: 10.3748/wjg.v23.i46.8217
Table 1 Characteristics of subjects n (%)
Healthy,(n = 10)Post-LT
Uncomplicated, (n = 10)NAS,(n = 10)
Age (yr)38 ± 1243 ± 1142 ± 9
Male9 (90.0)8 (80.0)8 (80.0)
BMI (kg/m2)23.3 ± 2.522.1 ± 2.622.4 ± 2.7
Current smoking3 (30.0)2 (10.0)0
Current drinking2 (20.0)00
Blood routine test
HB (g/L)122.5 ± 12.7129.0 ± 20.0127.4 ± 9.0
WBC (×109)6.0 ± 1.75.1 ± 2.25.2 ± 2.5
Neu (%)59.6 ± 14.866.4 ± 16.464.3 ± 20.0
Liver function
AST (U/L)21.3 (7.9-39.6)41.0 (13.0-93.0)57.1 (17.0-107.0)ac
ALT (U/L)20.1 (14.6-34.4)49.3 (12.0-89.1)57.3 (18.0-111.0)ac
ALP (U/L)77.3 ± 31.793.9 ± 17.2332.8 ± 52.4ac
GGT (U/L)27.2 ± 8.253.3 ± 35.6226.4 ± 83.4ac
TB (μmol/L)13.7 ± 6.727.4 ± 17.6104.43 ± 47.8ac
DB (μmol/L)5.4 ± 3.112.5 ± 8.643.8 ± 6.8ac
ALB (g/L)41.1 ± 2.941.9 ± 5.334.1 ± 5.0ac
Table 2 Operative characteristics of post-liver transplantation patients n (%)
Uncomplicated, (n = 10)NAS,(n = 10)P value
Primary disease
HBV cirrhosis8 (80.0)8 (80.0)0.568
HBV SALF0 (0.0)1 (10.0)
HCC1 (10.0)1 (10.0)
DILI1 (10.0)0 (0.0)
Child-Pugh classification
A1 (10.0)1 (10.0)0.834
B4 (40.0)4 (40.0)
C5 (50.0)5 (50.0)
WIT (min)7 ± 28 ± 00.108
CIT (h)7 ± 16 ± 10.291
Total operation duration (min)366 ± 80377 ± 620.893
Anhepatic phase (min)46 ± 1049 ± 70.513
Bleeding Volume (mL)1760 ± 3471311 ± 2680.329
T-tube insertion8 (80.00)7 (70.00)0.906
Median time from LT to NAS (m)-9 (5-13)-
Median time from LT to SC (m)15 (6-36)21 (13-32)0.129
Table 3 OTUs distribution in the three groups at different levels
Healthy (n = 10)Post-LT
Uncomplicated (n = 10)NAS (n = 10)
Phylum969 ± 43443 ± 75a568 ± 122a
Class969 ± 43443 ± 75a568 ± 122a
Order969 ± 43443 ± 75a567 ± 122a
Family889 ± 37413 ± 68a525 ± 110a
Genus414 ± 14254 ± 35a261 ± 44a
Species129 ± 788 ± 9a81 ± 11a
Table 4 α-diversity indexes in the three groups
Healthy(n = 10)Post-LT
Uncomplicated(n = 10)NAS(n = 10)
Chao1 Index649.30 ± 34.76269.70 ± 45.09a303.44 ± 76.86a
ACE834.03 ± 59.10346.72 ± 67.73a413.30 ± 88.68a
Simpson0.91 ± 0.010.81 ± 0.02a0.75 ± 0.04a
Shannon5.71 ± 0.263.73 ± 0.33a3.65 ± 0.50a
Table 5 Main bacterial families contributing to the changes in microbial community
PhylumClassFamilyHealthy (n = 10)Post-LT
Uncomplicated (n = 10)NAS (n = 10)
BacteroidetesBacteroidiaBacteroidaceae11.60% ± 5.33%16.20% ± 3.20%2.70% ± 0.97%ac
Prevotellaceae11.60% ± 4.56%0.00% ± 0.00%a0.70% ± 0.08%a
FirmicutesBacilliEnterococcaceae0.00% ± 0.00%1.20% ± 0.45%a2.60% ± 0.87%ac
Leuconostocaceae0.00% ± 0.00%0.70% ± 0.20%0.40% ± 0.05%
Streptococcaceae0.30% ± 0.11%3.90% ± 1.05%a8.60% ± 4.10%ac
Lachnospiraceae21.50% ± 6.78%9.80% ± 2.45%a10.50% ± 3.44%a
Ruminococcaceae30.90% ± 6.78%7.00% ± 3.16%a11.20% ± 2.33%a
Proteobacteriaγ-proteobacteriaEnterobacteriaceae0.70% ± 0.35%12.80% ± 2.56%a27.60% ± 7.06%ac
Pseudomonadaceae0.00% ± 0.00%0.00% ± 0.00%5.90% ± 3.16%ac
VerrucomicrobiaVerrucomicrobiaeVerrucomicrobiaceae0.10% ± 0.09%0.40% ± 0.16%a0.40% ± 0.05%a